V
41.79
0.86 (2.10%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Vera Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.5
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.50 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.97% |
| 机构持股比例 | 112.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Integral Health Asset Management, Llc | 31 Dec 2025 | 1,800,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 110.00 (HC Wainwright & Co., 163.22%) | 购买 |
| 中 | 99.00 (136.90%) | |
| 低 | 88.00 (Wolfe Research, 110.58%) | 购买 |
| 平均值 | 99.00 (136.90%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 41.23 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wolfe Research | 11 Mar 2026 | 88.00 (110.58%) | 购买 | 42.04 |
| HC Wainwright & Co. | 02 Mar 2026 | 110.00 (163.22%) | 购买 | 40.42 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合